Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 7
2017 5
2018 5
2019 8
2020 7
2021 12
2022 8
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma.
Heming M, Haessner S, Wolbert J, Lu IN, Li X, Brokinkel B, Müther M, Holling M, Stummer W, Thomas C, Schulte-Mecklenbeck A, de Faria F, Stoeckius M, Hailfinger S, Lenz G, Kerl K, Wiendl H, Meyer Zu Hörste G, Grauer OM. Heming M, et al. Among authors: schulte mecklenbeck a. Genome Med. 2022 Sep 24;14(1):109. doi: 10.1186/s13073-022-01110-1. Genome Med. 2022. PMID: 36153593 Free PMC article.
A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis.
Ostkamp P, Deffner M, Schulte-Mecklenbeck A, Wünsch C, Lu IN, Wu GF, Goelz S, De Jager PL, Kuhlmann T, Gross CC, Klotz L, Meyer Zu Hörste G, Wiendl H, Schneider-Hohendorf T, Schwab N. Ostkamp P, et al. Among authors: schulte mecklenbeck a. Sci Transl Med. 2022 Nov 30;14(673):eadc9778. doi: 10.1126/scitranslmed.adc9778. Epub 2022 Nov 30. Sci Transl Med. 2022. PMID: 36449599
Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.
Janoschka C, Lindner M, Koppers N, Starost L, Liebmann M, Eschborn M, Schneider-Hohendorf T, Windener F, Schafflick D, Fleck AK, Koch K, Deffner M, Schwarze AS, Schulte-Mecklenbeck A, Metz I, Meuth SG, Gross CC, Meyer Zu Hörste G, Schwab N, Kuhlmann T, Wiendl H, Stoll M, Klotz L. Janoschka C, et al. Among authors: schulte mecklenbeck a. Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2209944120. doi: 10.1073/pnas.2209944120. Epub 2022 Dec 27. Proc Natl Acad Sci U S A. 2023. PMID: 36574650 Free PMC article.
Stroke in Patients with Bacterial Meningitis: A Cohort Study and Meta-Analysis.
Beuker C, Werring N, Bonberg N, Strecker JK, Schmidt-Pogoda A, Schwindt W, Stracke P, Schulte-Mecklenbeck A, Gross C, Wiendl H, Minnerup H, Minnerup J. Beuker C, et al. Among authors: schulte mecklenbeck a. Ann Neurol. 2023 Jun;93(6):1094-1105. doi: 10.1002/ana.26618. Epub 2023 Mar 9. Ann Neurol. 2023. PMID: 36806294
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
Ostkamp P, Salmen A, Pignolet B, Görlich D, Andlauer TFM, Schulte-Mecklenbeck A, Gonzalez-Escamilla G, Bucciarelli F, Gennero I, Breuer J, Antony G, Schneider-Hohendorf T, Mykicki N, Bayas A, Then Bergh F, Bittner S, Hartung HP, Friese MA, Linker RA, Luessi F, Lehmann-Horn K, Mühlau M, Paul F, Stangel M, Tackenberg B, Tumani H, Warnke C, Weber F, Wildemann B, Zettl UK, Ziemann U, Müller-Myhsok B, Kümpfel T, Klotz L, Meuth SG, Zipp F, Hemmer B, Hohlfeld R, Brassat D, Gold R, Gross CC, Lukas C, Groppa S, Loser K, Wiendl H, Schwab N; German Competence Network Multiple Sclerosis (KKNMS) and the BIONAT Network. Ostkamp P, et al. Among authors: schulte mecklenbeck a. Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):e2018457118. doi: 10.1073/pnas.2018457118. Proc Natl Acad Sci U S A. 2021. PMID: 33376202 Free PMC article.
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response.
Teschner VE, Fleck AK, Walter C, Schwarze AS, Eschborn M, Wirth T, Steinberg OV, Schulte-Mecklenbeck A, Lu IN, Herrera-Rivero M, Janoschka C, Lünemann JD, Schwab N, Meyer Zu Hörste G, Varghese J, Gross CC, Pul R, Kleinschnitz C, Mader S, Meinl E, Stoll M, Wiendl H, Klotz L. Teschner VE, et al. Among authors: schulte mecklenbeck a. Ther Adv Neurol Disord. 2023 Dec 9;16:17562864231211077. doi: 10.1177/17562864231211077. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 38084102 Free PMC article.
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis.
Gross CC, Schulte-Mecklenbeck A, Wiendl H, Marcenaro E, Kerlero de Rosbo N, Uccelli A, Laroni A. Gross CC, et al. Among authors: schulte mecklenbeck a. Front Immunol. 2016 Dec 19;7:606. doi: 10.3389/fimmu.2016.00606. eCollection 2016. Front Immunol. 2016. PMID: 28066417 Free PMC article. Review.
Immune signatures of prodromal multiple sclerosis in monozygotic twins.
Gerdes LA, Janoschka C, Eveslage M, Mannig B, Wirth T, Schulte-Mecklenbeck A, Lauks S, Glau L, Gross CC, Tolosa E, Flierl-Hecht A, Ertl-Wagner B, Barkhof F, Meuth SG, Kümpfel T, Wiendl H, Hohlfeld R, Klotz L. Gerdes LA, et al. Among authors: schulte mecklenbeck a. Proc Natl Acad Sci U S A. 2020 Sep 1;117(35):21546-21556. doi: 10.1073/pnas.2003339117. Epub 2020 Aug 17. Proc Natl Acad Sci U S A. 2020. PMID: 32817525 Free PMC article.
Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis.
Eschborn M, Pawlitzki M, Wirth T, Nelke C, Pfeuffer S, Schulte-Mecklenbeck A, Lohmann L, Rolfes L, Pape K, Eveslage M, Bittner S, Gross CC, Ruck T, Wiendl H, Meuth SG, Klotz L. Eschborn M, et al. Among authors: schulte mecklenbeck a. Neurol Neuroimmunol Neuroinflamm. 2021 Oct 19;8(6):e1094. doi: 10.1212/NXI.0000000000001094. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34667129 Free PMC article.
57 results